• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    AbCellera Biologics Inc. - Common Shares (NQ: ABCL )

    2.950 +0.030 (+1.03%)
    Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,649,055
    Open 2.930
    Bid (Size) 2.900 (4)
    Ask (Size) 2.960 (38)
    Prev. Close 2.920
    Today's Range 2.850 - 2.960
    52wk Range 2.335 - 6.055
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    AbCellera to Present at Upcoming Investor Conferences in December and January
    From AbCellera Biologics Inc.
    Via Business Wire
    AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
    From AbCellera Biologics Inc.
    Via Business Wire

    Performance

    YTD
    -48.52%
    -48.52%
    1 Month
    N/A
    N/A
    3 Month
    +17.06%
    +17.06%
    6 Month
    +8.06%
    +8.06%
    1 Year
    -48.87%
    -48.87%

    More News

    Read More
    AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    AbCellera Reports Q3 2024 Business Results
    From AbCellera Biologics Inc.
    Via Business Wire
    AbCellera to Present at Upcoming Investor Conferences in November 2024
    From AbCellera Biologics Inc.
    Via Business Wire
    AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
    From AbCellera Biologics Inc.
    Via Business Wire
    AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
    From AbCellera Biologics Inc.
    Via Business Wire
    AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week
    Via Talk Markets
    AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th
    Via Talk Markets
    Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone!
    Via Talk Markets
    Topics Economy
    Exposures Economy
    AbCellera to Present at Upcoming Investor Conferences in September
    From AbCellera Biologics Inc.
    Via Business Wire
    Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week
    Via Talk Markets
    This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
    Via Benzinga
    AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD
    Via Talk Markets
    AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    AbCellera Reports Q2 2024 Business Results
    From AbCellera Biologics Inc.
    Via Business Wire
    AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines
    From AbCellera Biologics Inc.
    Via Business Wire
    AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD
    Via Talk Markets
    "Bubble" In AI/Semiconductor Stocks Began To Re-Inflate On Friday
    Via Talk Markets
    Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
    Via The Motley Fool
    AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD
    Via Talk Markets
    Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
    Via Talk Markets
    3 Biotech Stocks That Can Gain Exponentially By Leveraging AI
    Via Talk Markets
    AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
    From AbCellera Biologics Inc.
    Via Business Wire
    Largest Clinical-Stage BioTech Drug Stocks Declined 6%
    Via Talk Markets
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.